Allied Market Research
Loading...
0
New
New
2022
France Ultrasound Infertility Diagnosis And Treatment Market

France Ultrasound Infertility Diagnosis and Treatment Market by Care Pathway (Infertility Diagnostics, Punction, and Treatment Monitoring) and End User (Public Hospital with Infertility Department, Private Fertility Clinics and Ambulatory Centers): Opportunity Analysis and Industry Forecast, 2021–2030

A15402
Pages: 141
Jan 2022 | 120 Views
   
Author(s) : Shraddha Mali, Madhuvanti Divekar , Onkar Sumant
Tables: 56
Charts: 38
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the France Ultrasound Infertility Diagnosis And Treatment Market

Request Now !

Ultrasound Infertility Diagnosis and Treatment Market in France (Statistics & Outlook) 2030

The France ultrasound infertility diagnosis and treatment market was valued at $336.54 million in 2020, and is projected to reach $522.36 million by 2030, registering a CAGR of 4.4% from 2021 to 2030. Ultrasound scan is an important part of the diagnosis and treatment of infertility. Ultrasound-guided infertility diagnosis is a technique that is used to determine the cause of fertility in females and males with the help of ultrasound waves. It uses ultrasound waves to detect the details about the pelvic region that comprises ovaries, endometrium, and uterus. It can be used to assess the ovarian reserves, uterine shape & size, and whether the fallopian tubes are open or blocked at a specific site in greater detail.

Infertility is described as the male or female reproductive system's inability to conceive naturally. Fertility services assist both men and women in overcoming infertility. In vitro fertilization, fertility testing, intrauterine insemination, egg freezing, and embryo banking are all examples of fertility procedures. Single mothers, members of the LGBTQ community, and couples who are having difficulty conceiving frequently choose these procedures.

France-Ultrasound-Infertility-Diagnosis-and-Treatment-Market

Get more information on this report : Request Sample Pages

The major factors that drive the growth of France ultrasound infertility diagnosis and treatment market are rise in infertility rate, increase in trend of delayed pregnancies, and rise in number of median age of first-time mothers. In addition, alcohol binging, smoking & tobacco consumption, unhealthy lifestyle, increasing physical & psychological stress, drug use & medication, and environmental & occupational exposure lead to infertility issues, thus driving the growth of the France ultrasound infertility diagnosis and treatment market.

Moreover, rise in prevalence of sexually transmitted infections (STIs) as well as uterine disorders such as endometriosis, fibroids, and polycystic ovarian syndrome (PCOS) leads to infertility issues increase the chances of medically assisted procreation. Furthermore, surge in in vitro fertilization (IVF) due to their success rates and the recent approval by the French Government allowing lesbian couples and single women to access the procedure. Technological advancements in infertility diagnosis and development of minimally invasive procedures for diagnosis such as ultrasound-guided trans-vaginal needle aspiration/biopsy and core-needle testicular biopsy contribute toward the growth of the France ultrasound infertility diagnosis and treatment market.

Increase in overweight and obesity issues among women leads to menstrual disorders and anovulation and are at a higher risk of having a miscarriage or developing fertility issues, which significantly drive the market growth. On the contrary, high cost of infertility diagnosis procedures, risk associated after IVF procedure, and high cost of assisted reproductive technology are anticipated to hinder the France ultrasound infertility diagnosis and treatment market growth during the forecast period.

Impact of COVID-19 Pandemic on Ultrasound Infertility Diagnosis and Treatment Market in France (Pre & Post Analysis)

In addition, the COVID-19 outbreak is anticipated to have a negative impact on the growth of the France ultrasound infertility diagnosis and treatment market. A large number of clinics and hospitals throughout the world were reorganized to boost hospital capacity for COVID-19 patients. Owing to the rapidly increasing COVID-19 cases, non-essential processes faced a possible backlog. Furthermore, the lockdown hampered manufacturing and transportation of crucial hospital supplies. 

The infertility diagnostic procedures, embryo transfer procedures (IVF), whether fresh or frozen, suspension of elective surgeries and other non-urgent monitoring treatments were cancelled due to increase in incidence of COVID-19 cases. Moreover, assisted reproductive technology devices & consumables sales temporarily experienced unprecedented losses, as most elective medical procedures were postponed due to the COVID-19 pandemic. However, availability of vaccines and high immunization rate across the nation is expected to increase the infertility diagnostic procedures, thus boosting the France ultrasound infertility diagnosis and treatment market growth.

Furthermore, emerging France ultrasound infertility diagnosis and treatment market are expected to offer potential growth opportunities, due to improved healthcare infrastructure, increase in unmet healthcare needs, and rise in R&D activities.

France ultrasound infertility diagnosis and treatment market segmentation

The France ultrasound infertility diagnosis and treatment market is segmented into care pathway and end user. On the basis of care pathway, the market is segregated into infertility diagnostics, punction, and treatment monitoring. The infertility diagnostics segment is further classified into hysterosonography, hysterosonosalpyngography, and hysterosalpingo-foam sonography (HyFoSy). Furthermore, the punction segment is classified into ultrasound-guided trans-vaginal needle aspiration/biopsy and ultrasound-guided core-needle testicular biopsy. Moreover, the treatment monitoring segment comprises frozen embryo transfer services and ovulation monitoring.

By end user, the France ultrasound infertility diagnosis and treatment market is fragmented into public hospital with infertility department, private fertility clinics, and ambulatory centers and each are further segmented by care pathway into infertility diagnostics, punction, and treatment monitoring.

France Ultrasound Infertility Diagnosis and Treatment Market
By Care Pathway

Your browser does not support the canvas element.

Treatment Monitoring holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment review

Depending on the care pathway, the treatment monitoring segment dominated the France ultrasound infertility diagnosis and treatment market in 2020, and is expected to continue this trend during the forecast period.

By end user, the private fertility clinics segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.

The key players operating in the France ultrasound infertility diagnosis and treatment market are American Hospital of Paris, Amp Center St Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure, and Ramsay Healthcare Limited (Clinique De La Muette).

France Ultrasound Infertility Diagnosis and Treatment Market
By End User

Your browser does not support the canvas element.

Private Fertility Clinics segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the France ultrasound infertility diagnosis and treatment market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing France ultrasound infertility diagnosis and treatment market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the France ultrasound infertility diagnosis and treatment market.

Key Market Segments

  • By Care Pathways
    • Infertility Diagnostics
      • Hysterosonography
      • Hysterosonosalpyngography
      • Hysterosalpingo-foam Sonography (HyFoSy)
    • Punction
      • Ultrasound-guided trans-vaginal Needle Aspiration/Biopsy
      • Ultrasound-guided core-needle Testicular Biopsy
    • Treatment Monitoring
      • Frozen Embryo Transfer
      • Ovulation Monitoring
  • By End User
    • Public Hospital with Infertility Department
      • Infertility Diagnostics
      • Punction
      • Treatment Monitoring
    • Private Fertility Clinics
      • Infertility diagnostics
      • Punction
      • Treatment Monitoring
    • Ambulatory Centers
      • Infertility Diagnostics
      • Punction
      • Treatment Monitoring
  • Key Market Players
    • American Hospital of Paris
    • Amp Center St Roch
    • Amp Natecia Lyon
    • Centre Chirugical (Pierre Cherest Clinic)
    • Fertility Center-Parsi East
    • Hospital Cochin
    • Hospital Group Diaconesses Croix Saint-Simon
    • Maternité Des Bluets - Hospital Pierre Rouquès
    • Pointgyn-Pleasure
    • Ramsay Healthcare Limited (Clinique De La Muette)
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profile in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Porter’s five forces analysis
3.3.Top player positioning, 2020
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in infertility rate
3.4.1.2.Delayed pregnancies
3.4.1.3.Technological advancements in ultrasound-guided infertility diagnosis
3.4.1.4.Increase in disposable income and rise in awareness regarding infertility treatment

3.4.2.Restraint

3.4.2.1.High cost for infertility diagnosis and treatment

3.4.3.Opportunity

3.4.3.1.Rise in trend of fertility tourism

3.4.4.Impact analysis

3.5.Impact analysis of COVID-19 on the market
3.6.Company profiles of ultrasound providers in infertility diagnosis and treatment market

3.6.1.CANON INC. (CANON MEDICAL SYSTEMS CORPORATION)

3.6.1.1.Company overview
3.6.1.2.Company snapshot
3.6.1.3.Operating business segments
3.6.1.4.Product portfolio
3.6.1.5.Business performance

3.6.2.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

3.6.2.1.Company overview
3.6.2.2.Company snapshot
3.6.2.3.Operating business segments
3.6.2.4.Product portfolio
3.6.2.5.Business performance
3.6.2.6.Key strategic moves and developments

3.6.3.KONINKLIJKE PHILIPS N.V

3.6.3.1.Company overview
3.6.3.2.Company snapshot
3.6.3.3.Operating business segments
3.6.3.4.Product portfolio
3.6.3.5.Business performance
3.6.3.6.Key strategic moves and developments

3.6.4.MINDRAY MEDICAL INTERNATIONAL LIMITED

3.6.4.1.Company overview
3.6.4.2.Company snapshot
3.6.4.3.Operating business segments
3.6.4.4.Product portfolio

3.6.5.SIEMENS AG

3.6.5.1.Company overview
3.6.5.2.Company snapshot
3.6.5.3.Operating business segments
3.6.5.4.Product portfolio
3.6.5.5.Business performance
3.6.5.6.Key strategic moves and developments

CHAPTER 4:FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET, BY CARE PATHWAY

4.1.Overview

4.1.1.Market size and forecast

4.2.Infertility diagnostics

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type

4.2.2.1.Hysterosonography

4.2.2.1.1.Market size and forecast

4.2.2.2.Hysterosonosalpyngography

4.2.2.2.1.Market size and forecast

4.2.2.3.Hysterosalpingo-foam sonography (HyFoSy)

4.2.2.3.1.Market size and forecast

4.3.Punction

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Ultrasound-guided trans-vaginal needle aspiration/biopsy

4.3.2.1.1.Market size and forecast

4.3.2.2.Ultrasound-guided core-needle testicular biopsy

4.3.2.2.1.Market size and forecast

4.4.Treatment monitoring

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type

4.4.2.1.Frozen embryo transfer

4.4.2.1.1.Market size and forecast

4.4.2.2.Ovulation monitoring

4.4.2.2.1.Market size and forecast

CHAPTER 5:FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Public hospital with infertility department

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by care pathway

5.2.2.1.Infertility diagnostics

5.2.2.1.1.Market size and forecast

5.2.2.2.Punction

5.2.2.2.1.Market size and forecast

5.2.2.3.Treatment monitoring

5.2.2.3.1.Market size and forecast

5.3.Private fertility clinics

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by care pathway

5.3.2.1.Infertility diagnostics

5.3.2.1.1.Market size and forecast

5.3.2.2.Punction

5.3.2.2.1.Market size and forecast

5.3.2.3.Treatment monitoring

5.3.2.3.1.Market size and forecast

5.4.Ambulatory centers

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by care pathway

5.4.2.1.Infertility diagnostics

5.4.2.1.1.Market size and forecast

5.4.2.2.Punction

5.4.2.2.1.Market size and forecast

5.4.2.3.Treatment monitoring

5.4.2.3.1.Market size and forecast

CHAPTER 6:COMPANY PROFILES

6.1.AMERICAN HOSPITAL 0F PARIS

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio

6.2.AMP CENTER ST ROCH

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio

6.3.AMP NATECIA LYON

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio

6.4.CENTRE CHIRUGICAL (PIERRE CHEREST CLINIC)

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio

6.5.FERTILITY CENTER-PARSI EAST

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product portfolio

6.6.HOSPITAL COCHIN

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio

6.7.HOSPITAL GROUP DIACONESSES CROIX SAINT-SIMON

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio

6.8.MATERNITÉ DES BLUETS - HOSPITAL PIERRE ROUQUÈS

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segment
6.8.4.Product portfolio

6.9.POINTGYN - PLEASURE

6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio

6.10.RAMSAY HEALTHCARE LIMITED (CLINIQUE DE LA MUETTE)

6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.10.5.Business performance

LIST OF TABLES

TABLE 01.CANON: COMPANY SNAPSHOT
TABLE 02.CANON: OPERATING SEGMENTS
TABLE 03.CANON: PRODUCT PORTFOLIO
TABLE 04.GE: COMPANY SNAPSHOT
TABLE 05.GE: PRODUCT SEGMENTS
TABLE 06.GE: PRODUCT PORTFOLIO
TABLE 07.GE: KEY DEVELOPMENTS
TABLE 08.PHILIPS: COMPANY SNAPSHOT
TABLE 09.PHILIPS: PRODUCT SEGMENTS
TABLE 10.PHILIPS: PRODUCT PORTFOLIO
TABLE 11.PHILIPS: KEY DEVELOPMENTS
TABLE 12.MINDRAY: COMPANY SNAPSHOT
TABLE 13.MINDRAY: OPERATING SEGMENTS
TABLE 14.MINDRAY: PRODUCT PORTFOLIO
TABLE 15.SIEMENS: COMPANY SNAPSHOT
TABLE 16.SIEMENS: OPERATING BUSINESS SEGMENTS
TABLE 17.SIEMENS: PRODUCT PORTFOLIO
TABLE 18.SIEMENS: KEY DEVELOPMENTS
TABLE 19.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET, BY CARE PATHWAY, 2020–2030 ($MILLION)
TABLE 20.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR INFERTILITY DIAGNOSTICS, BY TYPE, 2020–2030 ($MILLION)
TABLE 21.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PUNCTION, BY TYPE, 2020–2030($MILLION)
TABLE 22.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR TREATMENT MONITORING, BY TYPE, 2020–2030 ($MILLION)
TABLE 23.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PUBLIC HOSPITAL WITH INFERTILITY DEPARTMENT, BY CARE PATHWAY, 2020–2030 ($MILLION)
TABLE 25.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PRIVATE FERTILITY CLINICS, BY CARE PATHWAY 2020–2030 ($MILLION)
TABLE 26.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR AMBULATORY CENTERS, BY CARE PATHWAY 2020–2030 ($MILLION)
TABLE 27.AMERICAN HOSPITAL: COMPANY SNAPSHOT
TABLE 28.AMERICAN HOSPITAL: OPERATING SEGMENT
TABLE 29.AMERICAN HOSPITAL: PRODUCT PORTFOLIO
TABLE 30.ST ROCH: COMPANY SNAPSHOT
TABLE 31.ST ROCH: OPERATING SEGMENTS
TABLE 32.ST ROCH: PRODUCT PORTFOLIO
TABLE 33.NATECIA: COMPANY SNAPSHOT
TABLE 34.NATECIA: OPERATING SEGMENTS
TABLE 35.NATECIA: PRODUCT PORTFOLIO
TABLE 36.CHIRUGICAL: COMPANY SNAPSHOT
TABLE 37.CHIRUGICAL: OPERATING SEGMENT
TABLE 38.CENTRE CHIRUGICAL: PRODUCT PORTFOLIO
TABLE 39.FERTILITY CENTER: COMPANY SNAPSHOT
TABLE 40.FERTILITY CENTER: OPERATING SEGMENT
TABLE 41.FERTILITY CENTER: PRODUCT PORTFOLIO
TABLE 42.COCHIN: COMPANY SNAPSHOT
TABLE 43.COCHIN: OPERATING SEGMENTS
TABLE 44.COCHIN: PRODUCT PORTFOLIO
TABLE 45.DIACONESSES: COMPANY SNAPSHOT
TABLE 46.DIACONESSES: OPERATING SEGMENT
TABLE 47.DIACONESSES: PRODUCT PORTFOLIO
TABLE 48.BLUETS: COMPANY SNAPSHOT
TABLE 49.BLUETS: OPERATING SEGMENTS
TABLE 50.BLUETS: PRODUCT PORTFOLIO
TABLE 51.POINTGYN: COMPANY SNAPSHOT
TABLE 52.POINTGYN: OPERATING SEGMENT
TABLE 53.POINTGYN: PRODUCT PORTFOLIO
TABLE 54.RAMSAY: COMPANY SNAPSHOT
TABLE 55.RAMSAY: OPERATING SEGMENTS
TABLE 56.RAMSAY: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION
FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE THREAT OF SUBSTITUTES
FIGURE 05.HIGH THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE INTENSITY OF RIVALRY
FIGURE 07.TOP PLAYER POSITIONING, 2020
FIGURE 08.IMPACT ANALYSIS
FIGURE 09.CANON: NET SALES, 2018–2020 ($MILLION)
FIGURE 10.CANON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 11.CANON: REVENUE SHARE BY REGION, 2020(%)
FIGURE 12.GE: NET SALES, 2018–2020 ($MILLION)
FIGURE 13.GE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 14.GE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 15.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 16.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 17.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 18.SIEMENS: NET SALES, 2018–2020 ($MILLION)
FIGURE 19.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 20.SIEMENS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 21.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR HYSTEROSONOGRAPHY, 2020–2030 ($MILLION)
FIGURE 22.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR HYSTEROSONOSALPYNGOGRAPHY , 2020–2030 ($MILLION)
FIGURE 23.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR HYFOSY, 2020–2030 ($MILLION)
FIGURE 24.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR ULTRASOUND GUIDED TRANS-VAGINAL NEEDLE ASPIRATION/BIOPSY, 2020–2030 ($MILLION)
FIGURE 25.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR ULTRASOUND GUIDED CORE-NEEDLE TESTICULAR BIOPSY, 2020–2030 ($MILLION)
FIGURE 26.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR FROZEN EMBRYO TRANSFER, 2020–2030 ($MILLION)
FIGURE 27.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR OVULATION MONITORING, 2020–2030 ($MILLION)
FIGURE 28.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR INFERTILITY DIAGNOSTICS, 2020–2030 ($MILLION)
FIGURE 29.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PUNCTION, 2020–2030 ($MILLION)
FIGURE 30.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR TREATMENT MONITORING, 2020–2030 ($MILLION)
FIGURE 31.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR INFERTILITY DIAGNOSTICS, 2020–2030 ($MILLION)
FIGURE 32.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PUNCTION, 2020–2030 ($MILLION)
FIGURE 33.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR TREATMENT MONITORING, 2020–2030 ($MILLION)
FIGURE 34.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR INFERTILITY DIAGNOSTICS, 2020–2030 ($MILLION)
FIGURE 35.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR PUNCTION, 2020–2030 ($MILLION)
FIGURE 36.FRANCE ULTRASOUND INFERTILITY DIAGNOSIS & TREATMENT MARKET FOR TREATMENT MONITORING, 2020–2030 ($MILLION)
FIGURE 37.RAMSAY: NET SALES, 2019–2021 ($MILLION)
FIGURE 38.RAMSAY: REVENUE SHARE, BY SEGMENT, 2021 (%)

 
 

This section provides the opinions of the top level CXOs in the France ultrasound infertility diagnosis and treatment market. According to the insights of CXOs, the market is expected to exhibit high growth due to increase in incidence of infertility issues, rise in trend of delayed pregnancies, and technological advancements for determination of infertility diagnosis & treatment monitoring services.

The CXOs further added that increase in smoking & tobacco usage, rise in alcohol consumption, rise in number of overweight & obese individuals, surge in prevalence of sexually transmitted diseases (STDs) lead to infertility disorders among males and females, thus strengthening the market growth.

Moreover, surge in demand for IVF due to its success rates and recent approval of the law in France of allowing single women and lesbians to get fertility treatment and access to medically assisted reproduction, including artificial insemination and IVF are anticipated to boost fertility tourism across the country.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of France ultrasound infertility diagnosis and treatment market is $336.54 million in 2020.

A. The forecast period for France ultrasound infertility diagnosis and treatment market is 2021 to 2030

A. The market value of France ultrasound infertility diagnosis and treatment market in 2021 is $353.03 million.

A. The base year is 2020 in France ultrasound infertility diagnosis and treatment market

A. Top companies such as American Hospital of Paris, Amp Center St Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure and Ramsay Healthcare Limited (Clinique De La Muette) held a high market position in 2020.

A. Treatment monitoring segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period due to surge in utilization of ovulation kits due to their simple usage and lower cost and further technological advancements is expected to drive the segment

A. Increase in prevalence of fertililty issues, delayed pregnancies and technological advancement in ultrasound infertility diagnosis is anticipated to drive the market in the forecast period.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
France Ultrasound Infertility Diagnosis And Treatment Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers